Skip to content

Menu

ChannelsPublishersSubscribe
LexBlog, Inc. logo
LexBlog, Inc. logo
ProductsSub-MenuBlogsPortalsTwentySyndicationMicrositesResource Center
Join
Search
Close
Join the Movement. Blog 4 Good

Another Study Warns of Pancreas Related Risks with Incretin Mimetics

By Kevin M. Hart on July 24, 2013
EmailTweetLikeLinkedIn

As we have previously reported, several other investigations have reported the possible increased risk of pancreatitis and pancreatic cancer from the use of incretin mimetic medications.

The British Medical Journal’s (BMJ) investigation into two classes of type-2 diabetes drugs has created cause for concern. The BMJ investigation focused on glucagon-like peptide (GLP-1) agonists and dipeptidylpeptidase-4 inhibitors. The preliminary results suggest that these types of drugs, classified as incretin mimetics, might have an adverse effect on pancreatic function. Even more concerning is the link between the medications and pancreatitis and pancreatic cancer. At one point in the BMJ study, researchers state that a “more coherent and worrying picture emerges” when evidence of the medications’ negative effects on pancreatic functions is considered. The study cites to “emerging and longstanding evidence” for its proposals. An excerpt of the study is available here.

If you or a loved one have suffered from pancreatitis or pancreatic cancer after taking Byetta, Januvia/Janumet or Victoza, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any potential claims.

 

Photo of Kevin M. Hart Kevin M. Hart

Kevin M. Hart is an expert Civil Trial Attorney as certified by the Supreme Court of New Jersey. Mr. Hart is also a member of the firm’s Litigation, Corporate Investigations & White Collar, Shareholder & Partner Disputes, Insurance Coverage & Liability, and Mass…

Kevin M. Hart is an expert Civil Trial Attorney as certified by the Supreme Court of New Jersey. Mr. Hart is also a member of the firm’s Litigation, Corporate Investigations & White Collar, Shareholder & Partner Disputes, Insurance Coverage & Liability, and Mass Tort practices.

Read more about Kevin M. HartEmail
Show more Show less
  • Posted in:
    Civil Litigation, Class Action & Mass Torts
  • Blog:
    Mass Torts Law Blog
  • Organization:
    Stark & Stark
  • Article: View Original Source

Stay Connected

Facebook LinkedIn Twitter RSS
Real Lawyers

Company

  • About LexBlog
  • Careers
  • Press
  • Contact LexBlog
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Terms of Service
  • RSS Terms of Service

Products

  • Products
  • Blogs
  • Portals
  • Twenty
  • Syndication
  • Microsites

Support

  • 1-800-913-0988
  • Submit a Request
  • Support Center
  • System Status
  • Resource Center

New to the Network

  • Red Clover Advisors Blog
  • Plane-ly Spoken
  • FCC Law Blog
  • California Employment Law
  • Privacy Compliance & Data Security
Copyright © 2021, LexBlog, Inc. All Rights Reserved.
Powered By LexBlog